Search Orphan Drug Designations and Approvals
-
| Generic Name: | (S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-(2-(5-(3-(2,4-dihydroxy-5-isopropylphenyl)-5-hydroxy-4H-1,2,4-triazol-4-yl)-1H-indol-1-yl)ethyl)piperidine-1-carboxylate |
|---|---|
| Date Designated: | 10/10/2019 |
| Orphan Designation: | Treatment of Small Cell Lung Cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Tarveda Therapeutics, Inc. 134 Coolidge Ave. Watertown, Massachusetts 02472 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
